drugset / Trial / NCT00742079
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
Phase 4
Completed
21 enrolled
Massachusetts General Hospital
National Institute of Mental Health (NIMH) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study will examine whether pretreatment with D-cycloserine before cognitive behavioral therapy can reduce impairments still present in people with stable cases of schizophrenia as well as determine which traits make schizophrenics most likely to respond to D-cycloserine treatment.
Timeline
- Start
- 2006-09
- Primary completion
- 2010-07
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cycloserine | Small molecule | 50 mg | — |